Monivent AB announces that the company has signed a Memorandum of Understanding (MOU) together with the American Academy of Pediatrics, AAP, an organization of over 67,000 pediatricians committed to improving the health of all infants and adolescents. This MOU states that the two organizations wish to establish a strategic alliance with the primary purpose of advancing the health and welfare for children and their families and to collaborate in areas of mutual interest that benefits this purpose.
As part of the common mission of improving newborn health, one aim is to use Monivent’s monitoring technology to gather ventilation data during newborn resuscitation at hospitals associated with the multi-center Delivery Room Intervention and Evaluation (DRIVE) Network. This network was convened by the AAP to study neonatal resuscitation practices and includes a number of academic centers across the United States.
“We are very excited about the opportunity to collaborate with the AAP and support the important research within the DRIVE Network. Being able to contribute to the common goal of improving health of all newborns is completely in line with Monivent’s vision. This alliance will also provide us with the opportunity to create a deeper customer understanding even before Neo100 is cleared by the FDA”, says Karin Dahllöf, CEO of Monivent.